{"transactions":[{"id":4636015,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":62911,"kind":"person","name":"SUPRAN BRYAN","position":1,"cik":"0001511797","reported_name":"SUPRAN BRYAN","relationship":{"officer":true,"officer_title":"EVP, CLO and Secretary"}}],"security":"Common Stock","published_at":"2026-10-06T20:12:25.000Z","date":"2026-10-02","kind":"sale","planned":false,"acquired":false,"shares":1758,"price":226.88,"value":398855.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units."}],"balance_after":12807,"source":{"system":"sec-edgar","filing":"0001178670-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511797/000117867026000068/form4.xml","form_type":"4"}},{"id":862446,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":62911,"kind":"person","name":"SUPRAN BRYAN","position":1,"cik":"0001511797","reported_name":"SUPRAN BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO and Secretary"}}],"security":"Stock Option  (right to buy)","published_at":"2026-03-05T00:29:40.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":3381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date."}],"balance_after":3381,"derivative":{"exercise_price":325.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":3381},"source":{"system":"sec-edgar","filing":"0001735276-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527626000049/edgardoc.xml","form_type":"4"}},{"id":862445,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":62911,"kind":"person","name":"SUPRAN BRYAN","position":1,"cik":"0001511797","reported_name":"SUPRAN BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO and Secretary"}}],"security":"Common Stock","published_at":"2026-03-05T00:29:40.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date."}],"balance_after":14565,"source":{"system":"sec-edgar","filing":"0001735276-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527626000049/edgardoc.xml","form_type":"4"}},{"id":1025191,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":62911,"kind":"person","name":"SUPRAN BRYAN","position":1,"cik":"0001511797","reported_name":"SUPRAN BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CLO and Secretary"}}],"security":"Common Stock","published_at":"2025-10-03T21:15:27.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":13026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date."}],"balance_after":13026,"source":{"system":"sec-edgar","filing":"0001735276-25-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000118/edgardoc.xml","form_type":"4"}}]}